Goserelin and preservation of ovarian function among breast cancer patients treated with adjuvant cytotoxic chemotherapy: results from a randomised trial.

被引：0
|
作者：
Sverrisdottir, A.
Nystedt, M.
Fornander, T.
机构：
[1] Univ Hosp, Karolinska Inst, Stockholm, Sweden
[2] Landspitali Univ Hosp, Reykjavik, Iceland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [41] OVARIAN-FUNCTION AND RECURRENCES WITH ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER
    SCHMIDTGOLLWITZER, K
    SCHONEGG, W
    SCHEIBER, A
    WESSEL, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1987, 47 (10) : 695 - 699
  • [42] OVARIAN-FUNCTION AND ADJUVANT CHEMOTHERAPY FOR EARLY BREAST-CANCER
    PADMANABHAN, N
    WANG, DY
    MOORE, JW
    RUBENS, RD
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06): : 745 - 748
  • [43] The impact on quality of life of adding chemotherapy (CT) or ovarian suppression (OS) to adjuvant tamoxifen (TAM): Outcomes from the UKNCRI Adjuvant Breast Cancer (ABC) trial.
    Brunt, AM
    Bliss, JM
    Benghiat, A
    Dawson, C
    Dewar, J
    Harnett, AN
    Hopwood, P
    Lawrence, D
    Trask, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 732S - 732S
  • [44] Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
    Janni, Wolfgang
    Rack, Brigitte Kathrin
    Fasching, Peter A.
    Haeberle, Lothar
    Tesch, Hans
    Lorenz, Ralf
    Schochter, Fabienne
    Tzschaschel, Marie
    De Gregorio, Amelie
    Fehm, Tanja N.
    Mueller, Volkmar
    Schneeweiss, Andreas
    Lichtenegger, Werner
    Beckmann, Matthias W.
    Scholz, Christoph
    Pantel, Klaus
    Friedl, Thomas W. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)
    Urruticoechea, Ander
    Arnedos, Monica
    Walsh, Geraldine
    Dowsett, Mitch
    Smith, Ian E.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 110 (03) : 411 - 416
  • [46] Can exercise influence survival following breast cancer: Results from a randomised, controlled trial.
    Hayes, Sandra Christine
    Steele, Megan
    Spence, Rosa
    Pyke, Christopher
    Saunders, Christobel
    Bashford, John
    Eakin, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC)
    Ander Urruticoechea
    Monica Arnedos
    Geraldine Walsh
    Mitch Dowsett
    Ian E. Smith
    Breast Cancer Research and Treatment, 2008, 110 : 411 - 416
  • [48] Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer
    Asgerdur Sverrisdottir
    Hemming Johansson
    Ulla Johansson
    Jonas Bergh
    Samuel Rotstein
    LarsErik Rutqvist
    Tommy Fornander
    Breast Cancer Research and Treatment, 2011, 128 : 755 - 763
  • [49] Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer
    Sverrisdottir, Asgerdur
    Johansson, Hemming
    Johansson, Ulla
    Bergh, Jonas
    Rotstein, Samuel
    Rutqvist, LarsErik
    Fornander, Tommy
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 755 - 763
  • [50] Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
    Wang, Siyuan
    Pei, Lin
    Hu, Taobo
    Jia, Mei
    Wang, Shu
    HUMAN REPRODUCTION, 2021, 36 (04) : 976 - 986
12345